Ziopharm Oncology Inc – ‘10-Q’ for 6/30/14 – ‘EXCEL’

On:  Thursday, 8/7/14, at 4:01pm ET   ·   For:  6/30/14   ·   Accession #:  1193125-14-300632   ·   File #:  1-33038

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    471K 
 2: EX-10.1     Material Contract                                   HTML    127K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
34: R1          Document and Entity Information                     HTML     38K 
24: R2          Balance Sheets                                      HTML    102K 
32: R3          Balance Sheets (Parenthetical)                      HTML     36K 
36: R4          Statements of Operations                            HTML     45K 
48: R5          Statement of Stockholders' Equity                   HTML     55K 
25: R6          Statements of Cash Flows                            HTML     96K 
31: R7          Business                                            HTML     25K 
22: R8          Summary of Significant Accounting Policies          HTML     19K 
16: R9          Recently Issued Accounting Pronouncements           HTML     19K 
49: R10         Restructuring                                       HTML     23K 
38: R11         Fair Value Measurements                             HTML     33K 
37: R12         Net Loss per Share                                  HTML     23K 
42: R13         Related Party Transactions                          HTML     24K 
43: R14         Commitments and Contingencies                       HTML     68K 
41: R15         Warrants                                            HTML     42K 
44: R16         Common Stock                                        HTML     19K 
33: R17         Stock-Based Compensation                            HTML     50K 
35: R18         Fair Value Measurements (Tables)                    HTML     29K 
40: R19         Net Loss per Share (Tables)                         HTML     22K 
52: R20         Warrants (Tables)                                   HTML     44K 
46: R21         Stock-Based Compensation (Tables)                   HTML     55K 
27: R22         Business - Additional Information (Detail)          HTML     19K 
39: R23         Restructuring - Additional Information (Detail)     HTML     40K 
30: R24         Assets and Liabilities Measured at Fair Value on    HTML     23K 
                Recurring Basis (Detail)                                         
14: R25         Potential Dilutive Shares Excluded from             HTML     23K 
                Computation of Diluted Net Loss Per Share (Detail)               
47: R26         Related Party Transactions - Additional             HTML     33K 
                Information (Detail)                                             
50: R27         Commitments and Contingencies - Additional          HTML    248K 
                Information (Detail)                                             
19: R28         Number of Warrants Outstanding (Detail)             HTML     20K 
18: R29         Warrants - Additional Information (Detail)          HTML     47K 
20: R30         Assumptions Used In Binomial Valuation Model and    HTML     26K 
                Black-Scholes Valuation Model (Detail)                           
21: R31         Warrant Exercise (Detail)                           HTML     26K 
23: R32         Common Stock - Additional Information (Detail)      HTML     29K 
13: R33         Stock-Based Compensation Expense on All Employee    HTML     22K 
                and Non-Employee Awards (Detail)                                 
45: R34         Stock-Based Compensation - Additional Information   HTML     39K 
                (Detail)                                                         
26: R35         Fair Value of Stock Options Assumptions Using       HTML     28K 
                Black-Scholes Option Valuation Model (Detail)                    
28: R36         Stock Option Activity Under Stock Option Plan       HTML     76K 
                (Detail)                                                         
15: R37         Summary of Unvested Restricted Stock (Detail)       HTML     41K 
51: XML         IDEA XML File -- Filing Summary                      XML     74K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX    113K 
17: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    506K 
 6: EX-101.INS  XBRL Instance -- ziop-20140630                       XML    767K 
 8: EX-101.CAL  XBRL Calculations -- ziop-20140630_cal               XML    104K 
 9: EX-101.DEF  XBRL Definitions -- ziop-20140630_def                XML    649K 
10: EX-101.LAB  XBRL Labels -- ziop-20140630_lab                     XML    931K 
11: EX-101.PRE  XBRL Presentations -- ziop-20140630_pre              XML    721K 
 7: EX-101.SCH  XBRL Schema -- ziop-20140630                         XSD    136K 
29: ZIP         XBRL Zipped Folder -- 0001193125-14-300632-xbrl      Zip    103K 

‘EXCEL’   —   IDEA Workbook of Financial Reports (.xls)

This is an IDEA Workbook.

	Download this Microsoft® Excel® .xls workbook
Web Archive:	This document is a Single File Web Page, also known as         a Web Archive file.  To view this Workbook file format,         your browser or editor must support Web Archive files.